Previous Close | $118.13 |
Intrinsic Value | $35.08 |
Upside potential | -70% |
Data is not available at this time.
Globe Life Inc. operates as a life and supplemental health insurance provider, primarily serving middle-income families in the United States. The company generates revenue through premiums from its diversified portfolio of life, accident, and health insurance products, distributed via direct-to-consumer and agency-based channels. Globe Life maintains a strong market position by focusing on underserved segments, leveraging cost-efficient underwriting, and maintaining high policy persistency rates. Its competitive edge lies in its targeted marketing strategies and disciplined risk management, which have enabled steady growth in a mature industry. The company operates in a highly regulated environment but benefits from stable demand for its core products, supported by demographic trends and consumer need for financial protection. Globe Life’s ability to maintain low lapse rates and efficient claims processing further solidifies its reputation as a reliable insurer in its niche.
Globe Life reported revenue of $5.78 billion for FY 2024, with net income reaching $1.07 billion, reflecting a robust net margin of approximately 18.5%. Diluted EPS stood at $12.63, demonstrating strong earnings power. Operating cash flow was $1.40 billion, significantly exceeding capital expenditures of $71 million, indicating efficient cash generation. The company’s high profitability is driven by disciplined underwriting and low operational overhead.
The company’s earnings power is underscored by its consistent ability to convert premiums into profits, with a return on equity likely in the mid-teens given its net income and equity base. Globe Life’s capital efficiency is evident in its ability to fund growth and dividends while maintaining a conservative leverage profile. Its operating cash flow coverage of dividends and buybacks remains strong.
Globe Life’s balance sheet shows $165 million in cash and equivalents against total debt of $2.74 billion, reflecting a manageable leverage ratio. The company’s debt is primarily long-term, with no near-term liquidity concerns. Its financial health is further supported by stable insurance reserves and a solid equity base, ensuring resilience against underwriting volatility.
Globe Life has demonstrated steady premium growth, supported by its focus on middle-market consumers. The company pays a dividend of $1.02 per share, with a payout ratio below 10% of net income, allowing for reinvestment and potential increases. Share buybacks have also been a tool for capital return, though the focus remains on organic growth and maintaining underwriting discipline.
The market values Globe Life at a premium relative to peers, reflecting its consistent profitability and low-risk profile. Investors likely price in stable earnings growth, given the company’s niche focus and efficient operations. The current P/E ratio, based on diluted EPS, suggests confidence in sustained performance.
Globe Life’s strategic advantages include its targeted market approach, cost-efficient distribution, and strong policy retention. The outlook remains positive, with demographic trends supporting demand for life and supplemental health products. Regulatory risks persist, but the company’s conservative underwriting and capital management position it well for long-term stability.
Company filings (10-K), investor presentations
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |